tradingkey.logo
tradingkey.logo
Search

Lantheus Holdings Inc

LNTH
Add to Watchlist
106.030USD
-0.170-0.16%
Close 06/23, 16:00ETQuotes delayed by 15 min
6.90BMarket Cap
25.08P/E TTM

TradingKey Stock Score of Lantheus Holdings Inc

Currency: USD Updated: 2026-06-22

Key Insights

Lantheus Holdings Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 1 out of 203 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 102.46.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Lantheus Holdings Inc's Score

Industry at a Glance

Industry Ranking
1 / 203
Overall Ranking
38 / 4577
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive

Lantheus Holdings Inc Highlights

StrengthsRisks
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow diseases to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Radiopharmaceutical Oncology diagnostics and therapeutics help healthcare professionals (HCPs) find, fight and follow cancer, with a focus on prostate cancer. Precision Diagnostic products assist HCPs to find and follow diseases, with a focus on cardiology. Strategic Partnerships focus on enabling precision medicine through the use of biomarker solutions, digital solutions, and radiotherapeutic platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, Neuraceq, and others. Its clinical candidates include LNTH-2404, NAV-4694, and PNT2002, among others. The Neuraceq (florbetaben F18 injection) is an F-18 PET imaging agent for Alzheimer’s disease.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 18.91% year-on-year.
Overvalued
The company’s latest PE is 25.12, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 77.80M shares, decreasing 7.09% quarter-over-quarter.
Held by Private Capital
Star Investor Private Capital holds 273.79K shares of this stock.

Analyst Rating

Based on 13 analysts
Buy
Current Rating
102.462
Target Price
-3.52%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

FAQs

How does TradingKey generate the Stock Score of Lantheus Holdings Inc?

The TradingKey Stock Score provides a comprehensive assessment of Lantheus Holdings Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Lantheus Holdings Inc’s performance and outlook.

How do we generate the financial health score of Lantheus Holdings Inc?

To generate the financial health score of Lantheus Holdings Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Lantheus Holdings Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Lantheus Holdings Inc.

How do we generate the company valuation score of Lantheus Holdings Inc?

To generate the company valuation score of Lantheus Holdings Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Lantheus Holdings Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Lantheus Holdings Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Lantheus Holdings Inc.

How do we generate the earnings forecast score of Lantheus Holdings Inc?

To calculate the earnings forecast score of Lantheus Holdings Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Lantheus Holdings Inc’s future.

How do we generate the price momentum score of Lantheus Holdings Inc?

When generating the price momentum score for Lantheus Holdings Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Lantheus Holdings Inc’s prices. A higher score indicates a more stable short-term price trend for Lantheus Holdings Inc.

How do we generate the institutional confidence score of Lantheus Holdings Inc?

To generate the institutional confidence score of Lantheus Holdings Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Lantheus Holdings Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Lantheus Holdings Inc.

How do we generate the risk management score of Lantheus Holdings Inc?

To assess the risk management score of Lantheus Holdings Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Lantheus Holdings Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Lantheus Holdings Inc.
KeyAI